France recorded 226 locally acquired West Nile virus cases and 31 chikungunya episodes with 216 cases as of November 16, 2026.
The total count of West Nile virus cases spans eight regions, including Provence-Alpes-Côte d’Azur, Occitanie, and Île-de-France. While most cases have been traced to specific departments, 20 infections lack a confirmed transmission location, and the origin of one additional case remains undetermined, Outbreak News Today reported.
The data also confirmed 440 equine outbreaks, which accounts for 65% of Europe’s 680 equine outbreaks, and 21 avian outbreaks.
Beyond West Nile virus, France has seen 31 episodes of locally acquired chikungunya this year, resulting in 216 total cases. According to travelandtourworld.com, this represents the highest seasonal volume and episode count since enhanced surveillance measures were first implemented in 2006.

Dengue transmission has remained lower, with eight cases identified across five episodes in regions including Occitanie, Provence-Alpes-Côte d’Azur, and Nouvelle-Aquitaine. Surveillance data from Outbreak News Today notes that no new episodes of dengue or chikungunya were reported during the week leading up to November 16.
| Virus Type | Total Episodes | Total Cases |
|---|---|---|
| Chikungunya | 31 | 216 |
| Dengue | 5 | 8 |
| West Nile Virus | N/A | 226 |
The surge in local transmission occurs alongside broader European trends. By mid-November, public health agencies across the European Union and European Economic Area had documented over 2,000 locally acquired West Nile virus cases, with Italy accounting for a large share of the continent's disease burden, travelandtourworld.com reported. As of September 30, 2026, global chikungunya cases reached 271,223 across 26 countries, contributing to ongoing travel-associated importations into Western and Southern Europe.
Beyond established arboviruses, French authorities documented the country’s first human Shamonda virus infection on October 23, 2026. This adds a new diagnostic challenge to surveillance that, prior to this year, had focused primarily on managing the record-breaking prevalence of established mosquito-borne diseases.
Related reading